Skip to content
Open access · CC-BY via OpenAlex

Modeling Parkinson’s Disease With the Alpha-Synuclein Protein

Mónica Gómez-Benito, Noelia Granado, Patricia García‐Sanz, Anne Michel, Mireille Dumoulin, Rosario Moratalla

Frontiers in Pharmacology · 2020 · ▲ 439 citations

Abstract

gene, which encodes α-Syn, cause familial forms of PD and are the basis of sporadic PD risk. Given the role of the α-Syn protein in the pathology of PD, animal models that reflect the dopaminergic neuronal loss and the widespread and progressive formation of α-Syn aggregates in different areas of the brain constitute a valuable tool. Indeed, animal models of PD are important for understanding the molecular mechanisms of the disease and might contribute to the development and validation of new therapies. In the absence of animal models that faithfully reproduce human PD, in recent years, numerous animal models of PD based on α-Syn have been generated. In this review, we summarize the main features of the α-Syn pre-formed fibrils (PFFs) model and recombinant adeno-associated virus vector (rAAV) mediated α-Syn overexpression models, providing a detailed comparative analysis of both models. Here, we discuss how each model has contributed to our understanding of PD pathology and the advantages and weakness of each of them. SIGNIFICANCE: Here, we show that injection of α-Syn PFFs and overexpression of α-Syn mediated by rAAV lead to a different pattern of PD pathology in rodents. First, α-Syn PFFs models trigger the Lewy body-like inclusions formation in brain regions directly interconnected with the injection site, suggesting that there is an inter-neuronal transmission of the α-Syn pathology. In contrast, rAAV-mediated α-Syn overexpression in the brain limits the α-Syn aggregates within the transduced neurons. Second, phosphorylated α-Syn inclusions obtained with rAAV are predominantly nuclear with a punctate appearance that becomes diffuse along the neuronal fibers, whereas α-Syn PFFs models lead to the formation of cytoplasmic aggregates of phosphorylated α-Syn reminiscent of Lewy bodies and Lewy neurites.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
OpenAlex
DOI
10.3389/fphar.2020.00356
Canonical
link ↗
Fetched
2026-10-20 MST

Cite this

APA
Gómez-Benito, M., Granado, N., García‐Sanz, P., Michel, A., Dumoulin, M., &amp; Moratalla, R. (2020). Modeling Parkinson’s Disease With the Alpha-Synuclein Protein. <em>Frontiers in Pharmacology</em>. https://doi.org/10.3389/fphar.2020.00356
Vancouver
Gómez-Benito M, Granado N, García‐Sanz P, Michel A, Dumoulin M, Moratalla R. Modeling Parkinson’s Disease With the Alpha-Synuclein Protein. Frontiers in Pharmacology. 2020. doi:10.3389/fphar.2020.00356.
BibTeX
@article{mnica2020Modeli, title = {Modeling Parkinson’s Disease With the Alpha-Synuclein Protein}, author = {Mónica Gómez-Benito and Noelia Granado and Patricia García‐Sanz and Anne Michel and Mireille Dumoulin and Rosario Moratalla}, journal = {Frontiers in Pharmacology}, year = {2020}, doi = {10.3389/fphar.2020.00356}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings